AquaVac* IPN Injection
 Description: Injection administered vaccine containing protein antigens cloned from VP2 and VP3 of the IPN Virus and produced in a yeast expression system. The antigens are contained in a Non Mineral Oil based adjuvant system
Formulation: Protein antigens in a non-mineral oil adjuvant.
Target Species: Salmonids
Key Benefits:
- The low side effect adjuvant system ensures that the vaccine can be used early in the freshwater cycle thereby maximizing the protection against IPN virus in both freshwater and Sea Water.
- The vaccine has been shown not to cause growth penalties or other severe side effects when used according to the recommendations.
Label Indications: This product is recommended for the reduction in mortality due to IPN disease caused by IPN virus in healthy salmonids.
Dosage and Administration:
Injection Vaccination Method:
- The vaccine is recommended for fish of 25g and larger. The fish should be anaesthetized prior to vaccination with an anesthetic approved for use in fish.
- The vaccine is administered by intraperitoneal injection.
- Dosage: 0.1ml per fish.
Withdrawal Time: Zero days**
**Approved species, claims and withdrawal times may vary from country to country. Please check your local package insert or contact your local Schering-Plough Animal Health representative for more details.
Product Presentation: AquaVac* IPN is available in 500ml high-density polyethylene flat bottles.
Storage Conditions: Store at 2oC to 8oC . Do not freeze. Protect from light. Use entire contents when first opened.
Precautions: Minimum fish size for injection: 25g. Avoid self-injection. Target Diseases
This literature is intended for international use. Specific product details of indications, registration license status, and trademarks, etc. may vary from country to country. Users should check the license status, local label and/or data sheet for exact specifications of usage or contact the local Intervet/Schering-Plough Animal Health representative.
* Trademark
|
